Trademark search for:

ALPIVAB

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2016-11-30 — Application filed
2017-03-09 — Sn assigned for sect 66a appl from ib
2017-03-10 — Approved for pub - principal register
2017-03-10 — Application filed
2017-03-10 — Assigned to examiner
2017-03-14 — Application filed
2017-04-05 — Notice of publication
2017-04-25 — Published for opposition
2017-07-11 — Registered-principal register
2017-08-10 — Grant of protection created, to be sent to ib
2017-08-11 — Final disposition recorded
2017-08-11 — Final disposition recorded
2017-09-01 — Notification processed by ib
2021-12-11 — Change of owner received from ib
2024-01-26 — Cancelled section 71
2024-01-26 — Final status recorded
2024-09-27 — Total invalidation of reg ext protection created
2024-10-03 — Total invalidation of reg ext protection sent to ib
2024-10-03 — Invalidation processed
2024-10-26 — Total invalidation processed by the ib

Owner Information

BioCryst Pharmaceuticals, Inc.
US

Seqirus UK Limited
GB

Correspondent

Baker & McKenzie LLP
100 New Bridge Street
London EC4V 6JA,
UNITED KINGDOM

Filing Details

Filing Date:
2016-11-30

Status Date:
2024-01-26

Category:
Pharmaceuticals

Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.